Press Releases
Media Focus
Navigating the maelstrom of M&A activity: what do CDMOs do next?
Finding a well-rounded service provider can be challenging, particularly in new, emerging fields such as mRNA and cell and gene therapy. In this panel discussion, Seokjin Chang, Director of Market Intelligence at Samsung Biologics, explains how finding a CDMO partner with proven end-to-end capabilities and expert personnel is the key for success.
Finding a well-rounded service provider can be challenging, particularly in new, emerging fields such as mRNA and cell and gene therapy. In this panel discussion, Seokjin Chang, Director of Market Intelligence at Samsung Biologics, explains how finding a CDMO partner with proven end-to-end capabilities and expert personnel is the key for success.
